Form D · Biotechnology
NuProbe Global
George Town, E9 · CIK 0001931370
Offering snapshot reported May 31, 2022 · SEC filing
- Reported sold
- $42.2M Offering amount: $57.7M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 31, 2022 | Initial | $42,200,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $613K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-447552
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| China eCapital Holdings, Ltd. | 150251 |
Source: Form D, filed May 31, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Penghui (Kevin) Chen | Director |
| Li Mei | Director |
| Di Xu | Director |
| Chai Yingshuang | Director, Executive |
| Chen Yundi | Director |
| David Zhang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Quality Corporate Services Ltd, Ste 102 Cannon Place, Po Box 712, N. Sound Rd.
George Town, E9, KY1-9006
George Town, E9, KY1-9006